Fundación Pública Galega de Medicina Xenómica
Centro de investigación
Instituto de Investigación Sanitaria Biobizkaia
Barakaldo, EspañaPublicacións en colaboración con investigadores/as de Instituto de Investigación Sanitaria Biobizkaia (11)
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
SARS-CoV-2 infection in children with cystic fibrosis: A cross-sectional multicenter study in Spain. New waves, new knowledge
Pediatric Pulmonology, Vol. 58, Núm. 11, pp. 3195-3205
2022
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2019
-
Molecular and clinical characterization of a novel nonsense variant in exon 1 of the upf3b gene found in a large spanish basque family (Mrx82)
Frontiers in Genetics, Vol. 10, Núm. OCT
2018
-
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
Human Mutation, Vol. 39, Núm. 5, pp. 593-620
-
The dietary antioxidant piceatannol inhibits adipogenesis of human adipose mesenchymal stem cells and limits glucose transport and lipogenic activities in adipocytes
International Journal of Molecular Sciences, Vol. 19, Núm. 7
2017
-
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
Nature Genetics, Vol. 49, Núm. 12, pp. 1767-1778
-
The relevance of precision epitope mapping for accurate oncologic diagnostic based on PTEN protein expression in tumours
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 28
2016
-
Limited beneficial effects of piceatannol supplementation on obesity complications in the obese Zucker rat: gut microbiota, metabolic, endocrine, and cardiac aspects
Journal of Physiology and Biochemistry, Vol. 72, Núm. 3, pp. 567-582
-
Potential renoprotective effects of piceatannol in ameliorating the early-stage nephropathy associated with obesity in obese Zucker rats
Journal of Physiology and Biochemistry, Vol. 72, Núm. 3, pp. 555-566